Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opsin Receptors in Melasma Treated with Retinoic Acid and Sunscreen
NCT04417348Completed
- Sponsor
- Universidad Autónoma de San Luis Potosí
- Start
- Jan 2019
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of tretinoin in melasma (2 arms), sponsored by Universidad Autónoma de San Luis Potosí. Primary endpoint: Melasma Activity and Severity Index at 3 months. Started Jan 2019; status: completed.
02
Drugs
tretinoin
03
Conditions
melasma
Beyond the preview
Go deeper on NCT04417348.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04417348.